When renowned medical news publications such as the New England Journal of Medicine start excluding certain publications from advanced access to embargoed journal articles, it begs the question – is this the medical field’s version of a ‘don’t ask, don’t tell’ policy? The sharp criticism from experts like Ivan Oransky, MD, highlights the potential implications
Health
In today’s society, where the media is saturated with bad news, important trends can often get lost in the noise. One concerning trend that is on the rise is the neglect and abuse of dependent persons. Neglecting the care of a dependent person can lead to serious criminal charges, such as those outlined in Pennsylvania’s
The New England Journal of Medicine (NEJM) has recently announced that it will be limiting access to embargoed journal articles for certain publications. According to Dawn Peters, director of strategic communications & media relations at NEJM Group, news outlets that cater to physician readers will no longer meet the criteria for embargoed access. This decision
A groundbreaking treatment candidate for amyotrophic lateral sclerosis (ALS) has shown promising results in the phase IIb PARADIGM trial. Developed as a formulation of two FDA-approved drugs, ciprofloxacin and celecoxib, PrimeC demonstrated positive safety outcomes for ALS patients, with similar results to those treated with a placebo. Massachusetts General Hospital’s Merit Cudkowicz, MD, MSc, presented
The use of antipsychotics in dementia patients has long been a topic of concern due to potential adverse outcomes. A recent population-based matched cohort study from the U.K. shed light on the increased risk associated with antipsychotic use in this vulnerable population. The study, which included more than 170,000 adults with dementia, revealed that those
The results of the open-label, phase II Galactic53 trial suggest that Viltolarsen (Viltepso) is well tolerated by boys and men with Duchenne muscular dystrophy (DMD). There were no new safety signals reported during the trial, offering a glimmer of hope for those living with this devastating disease. The exon-skipping therapy showed a potential clinical benefit
Dallas anesthesiologist Raynaldo Rivera Ortiz Jr., MD, has recently been convicted for his actions that led to the death of a coworker and several cardiac emergencies involving patients. This shocking incident sheds light on the importance of medical professionals following proper protocols and ensuring patient safety at all times. In another troubling case, two doctors
The frustration and challenges associated with prior authorization for newer, highly effective cholesterol-lowering drugs are still prevalent in the medical field. Despite some improvements in access to these medications, the process remains arduous and time-consuming for healthcare providers. Dr. Christie Ballantyne of Baylor College of Medicine in Houston expressed his discontent with the current state
A 28-year-old woman presented with a gradually expanding mass in the inside corner of her left eye, leading to a baffling case for medical professionals. Upon further investigation, it was discovered that the patient had been on a humanitarian mission in the Democratic Republic of Congo where the lump had initially appeared and continued to
The testimony given by Republican lawmakers during the hearing of the House Committee on Oversight and Accountability highlights the challenges faced by the FDA with regards to the authorization of COVID-19 vaccines. Rep. Paul Gosar criticized the FDA for granting emergency use authorization of the vaccines, arguing that they do not stop virus transmission and